Cargando…

Case Report: Pediatric myeloid/lymphoid neoplasm with eosinophilia and PDGFRA rearrangement: The first case presenting as B-lymphoblastic lymphoma

According to the latest WHO classification of hematopoietic malignancies, myeloid and lymphoid neoplasms with eosinophilia and gene rearrangements include three specific rare diseases and one provisional entity. Myeloid/lymphoid neoplasms with platelet-derived growth factor receptor alpha (PDGFRA) r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akiely, Reem, Almasri, Farah, Almasri, Nidal, Abu-Ghosh, Amal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794852/ https://www.ncbi.nlm.nih.gov/pubmed/36589160 http://dx.doi.org/10.3389/fped.2022.1059527

Ejemplares similares

Myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA presenting as myeloid sarcoma
por: Barouqa, Mohammad, et al.
Publicado: (2022)

A tricky and rare cause of pulmonary eosinophilia: myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA
por: Zanelli, Magda, et al.
Publicado: (2019)

Complete response of myeloid/lymphoid neoplasms with PDGFRA rearrangement presenting as leukemia/myeloid sarcoma to imatinib monotherapy
por: Ma, Rui, et al.
Publicado: (2019)

Myeloid/lymphoid neoplasm with eosinophilia and BCR/FGFR1 rearrangement with transformation to cortical T-lymphoblastic lymphoma and erythroid precursors: a case report
por: Isaza, Alejandro Pineda, et al.
Publicado: (2023)

Imatinib-Associated Tumor Lysis Syndrome in a Patient With Myeloid Neoplasm With Eosinophilia and PDGFRA Rearrangement: A Case Report and Review of the Literature
por: Socola, Francisco, et al.
Publicado: (2017)

P1073: MUTATIONAL LANDSCAPE AND CLINICAL OUTCOMES OF PATIENTS WITH MYELOID AND LYMPHOID NEOPLASMS WITH EOSINOPHILIA (MLN-EOS) AND ABNORMALITIES OF PDGFRA, PDGFRB, FGFR1, FLT3 AND JAK REARRANGEMENT
por: Zhang, Y., et al.
Publicado: (2022)

Myeloid/lymphoid neoplasms associated with eosinophilia and rearrangements of PCM1::JAK2 with erythroblastic sarcoma: a case report and literature review
por: Zhang, Lina, et al.
Publicado: (2023)

An Intriguing Case of Eosinophilia with FIP1L1/PDGFRA Rearrangement Who Presented as Thrombotic Thrombocytopenic Purpura
por: Alshehri, Hassan, et al.
Publicado: (2019)

Case Report: Evolution of KIT D816V-Positive Systemic Mastocytosis to Myeloid Neoplasm With PDGFRA Rearrangement Responsive to Imatinib
por: Sciumè, Mariarita, et al.
Publicado: (2021)

A rare cause of persistent leukocytosis with massive splenomegaly: Myeloid neoplasm with BCR-PDGFRA rearrangement—Case report and literature review
por: Gao, Lu, et al.
Publicado: (2022)

T-Cell Lymphoblastic Lymphoma Arising in the Setting of Myeloid/Lymphoid Neoplasms with Eosinophilia: LMO2 Immunohistochemistry as a Potentially Useful Diagnostic Marker
por: Zanelli, Magda, et al.
Publicado: (2021)

An intriguing case of a paravertebral extramedullary erythropoiesis presenting as tumor‐mimicking lesion in a patient with eosinophilia with FIP1L1‐PDGFRA rearrangement
por: Farah, Sassi, et al.
Publicado: (2022)

Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
por: Romagnoli, Simone, et al.
Publicado: (2021)

Myeloid neoplasm with eosinophilia and rearrangement of platelet-derived growth factor receptor beta gene in children: Two case reports
por: Wang, Shi-Chong, et al.
Publicado: (2021)

The diagnostic challenges and clinical course of a myeloid/lymphoid neoplasm with eosinophilia and ZBTB20-JAK2 gene fusion presenting as B-lymphoblastic leukemia
por: Lee, Winston Y., et al.
Publicado: (2020)

Novel FIP1L1::KIT fusion in a myeloid neoplasm with eosinophilia, T-lymphoblastic transformation, and dasatinib response
por: Alsouqi, Aseel, et al.
Publicado: (2023)

Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy
por: Chalmers, Z R, et al.
Publicado: (2015)

Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1-PDGFRA-Associated Myeloid Neoplasm With Eosinophilia
por: Jain, Juhi, et al.
Publicado: (2020)

A novel t(3;13)(q13;q12) translocation fusing FLT3 with GOLGB1: toward myeloid/lymphoid neoplasms with eosinophilia and rearrangement of FLT3?
por: Troadec, E, et al.
Publicado: (2017)

Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort
por: Metzgeroth, Georgia, et al.
Publicado: (2023)

PDGFR(β)-Rearranged Myeloid Neoplasm with Marked Eosinophilia in a 37-Year-Old Man; And a Literature Review
por: Andrei, Mirela, et al.
Publicado: (2017)

Myeloid Neoplasia and Lymphoblastic Lymphoma with Eosinophilia After Radioactive Iodine: A Case Report
por: Büyükşimşek, Mahmut, et al.
Publicado: (2018)

FIP1L1-PDGFRA molecular analysis in the differential diagnosis of eosinophilia
por: Loules, Gedeon, et al.
Publicado: (2009)

Myeloid/lymphoid neoplasms with eosinophilia/basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition
por: Yao, Jinjuan, et al.
Publicado: (2020)

t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity
por: Mueller, Sarah B., et al.
Publicado: (2022)

Myeloid/Lymphoid Neoplasm With FGFR1 Rearrangement Accompanying RUNX1 and NOTCH1 Gene Mutations
por: Wang, Xiaoxue, et al.
Publicado: (2019)

Myeloproliferative neoplasm with eosinophilia and T-lymphoblastic lymphoma with ETV6–LYN gene fusion
por: Telford, N, et al.
Publicado: (2016)

The role of eosinophil morphology in distinguishing between reactive eosinophilia and eosinophilia as a feature of a myeloid neoplasm
por: Goasguen, Jean E., et al.
Publicado: (2020)

International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms
por: Gianelli, Umberto, et al.
Publicado: (2022)

CCDC88C‐FLT3 gene fusion in CD34‐positive haematopoietic stem and multilineage cells in myeloid/lymphoid neoplasm with eosinophilia
por: Kurihara, Yuya, et al.
Publicado: (2022)

Comprehensive response criteria for myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: a proposal from the MLN International Working Group
por: Shomali, William, et al.
Publicado: (2023)

A TRIP11:: FLT3 gene fusion in a patient with myeloid/lymphoid neoplasm with eosinophilia and tyrosine kinase gene fusions: a case report and review of the literature
por: Venable, Elise R., et al.
Publicado: (2023)

Eosinophilia in Amoxicillin-Induced Rash in Infectious Mononucleosis
por: Abreu, Ana, et al.
Publicado: (2023)

P1063: A SINGLE CENTER EXPERIENCE OF DIAGNOSTICS AND TREATMENT OF RARE MYELOID/LYMPHOID NEOPLASMS WITH PDGFRB GENE REARRANGEMENT
por: Nemchenko, Irina, et al.
Publicado: (2023)

Incidental detection of myeloid/lymphoid neoplasms with fibroblast growth factor receptor 1 rearrangement on fluorodeoxyglucose positron emission tomography
por: Kobayashi, Hiroki, et al.
Publicado: (2023)

Immunoglobulin and T-cell receptor gene rearrangement analysis in malignant lymphoid neoplasms.
por: Park, C. K., et al.
Publicado: (1994)

FIP1L1‐PDGFRA fusion gene in T‐lymphoblastic lymphoma: A case report
por: Ali, Salhah, et al.
Publicado: (2022)

Chronic eosinophilic leukemia with FIP1L1-PDGFRA rearrangement
por: Kim, Tae Hee, et al.
Publicado: (2016)

PB2180: TREATMENT CHALLENGES OF COEXISTING MYELOID AND LYMPHOID NEOPLASM- A CASE REPORT
por: Smiljanic, Mihailo, et al.
Publicado: (2023)

The Surgical Management of the Rare Neurogenic Myositis Ossificans of the Hip: A Report of 3 Cases
por: Hammad, Yazan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pcmaudq570ore2cpdti2uiks78